Sage Journals: Discover world-class research

Abstract

Contraction induced by 124 mM potassium followed the depolarization of smooth-muscle cells and activation of potential-operated calcium channels in human temporal arteries. The contraction elicited consisted of two phases, one rapid and one slowly developing stable phase; both were affected by the two calcium entry blockers flunarizine and nimodipine but at significantly different concentrations. In calcium-free medium 124 mM potassium resulted in a weak contraction. Addition of calcium caused a concentration-dependent contraction that was attenuated by the calcium entry blockers at concentrations comparable to those inhibiting the second phase. The results suggested that in human temporal arteries flunarizine and nimodipine act as calcium entry blockers; there was good correlation with the therapeutic plasma concentration for nimodipine but not for flunarizine.

Keywords

Flunarizine nimodipine vasomotor reactivity

Get full access to this article

View all access options for this article.

References

Havanka-Kanniainen

Hokkanen

Myllylä

VV.

Efficacy of nimodipine in the prophylaxis of migraine.Cephalalgia 1985;5:39–43.

Meyer

Hardenberg

Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches.Headache 1983;23:266–77.

Gelmers

HJ.

Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine.Headache 1983;23:106–9.

Diamond

Schenbaum

Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.Headache 1983;23:39–42.

Louis

Spierings

ELH.

Comparison of flunarizine (Sibelium®) and pizotifen (Sandomigran®) in migraine treatment: a double-blind study.Cephalalgia 1982;2:197–203.

Louis

A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium®) in migraine.Headache 1981;21:235–9.

Mendenopoulous

Manafi

Logothetis

Bostantjopoulos

Flunarizine in the prevention of classical migraine: a placebo controlled evaluation.Cephalalgia 1985;5:31–7.

Jensen

Tfelt-Hansen

Lauritzen

Olesen

Clinical trial of nimodipine for single attacks of classic migraine.Cephalalgia 1985;5:125–31.

Fleckenstein

Calcium antagonism in heart and smooth muscle.Experimental facts and therapeutic prospects.New York:Wiley-Interscience 1983,1–399.

10.

Dalessio

DJ.

Wolff's headache and other head pain.New York:Oxford University Press 1980:1–473.

11.

Högestätt

Andersson

K-E

Edvinsson

Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels.Acta Physiol Scand 1983;117:49–61.

12.

Ebashi

Regulation of muscle contraction.Proc R Soc Lond [Biol] 1980;207:259–86.

13.

Högestätt

Andersson

K-E.

Mechanisms behind the biphasic contractile response to potassium depolarization in isolated rat cerebral arteries.J Pharmacol Exp Ther 1984;228:187–95.

14.

Murphy

KMM

Gould

Largent

Snyder

SH.

A unitary mechanism of calcium antagonist drug action.Proc Natl Acad Sci USA 1983;80:860–4.

15.

Spedding

Calcium antagonist subgroups.Trends Pharmacol Sci 1985;6:109–14.

16.

Auer

LM.

Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms.Neurosurgery 1984;15:57–66.

17.

Skärby

Högestätt

Andersson

K-E.

Influence of extracellular calcium and nifedipine on a₁- and a₂ -adrenoceptor-mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries.Acta Physiol Scand 1984;123:445–56.

18.

Brandt

Andersson

K-E

Edvinsson

Ljunggren

Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries.J Cereb Blood Flow Metab 1981;1:339–47.

Effects of Extracellular Calcium and of the Calcium Entry Blockers Flunarizine and Nimodipine on Contractile Responses in Human Temporal Arteries

Abstract

Keywords

Get full access to this article

References